Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 124.98MWorking Capital
VS
Market
Sector
Industry
History
$ 1.74Close
$ 1.05 - $ 8.57 52-Week Range
Ticker Information
Ticker
ACRVCompany Name
ACRIVON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQACRIVON THERAPEUTICS INC - Working Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ACRV - Working Capital Historical data
| Date | Current Assets | Current Liabilities | Working Capital |
|---|---|---|---|
| 6/30/2025 | $ 138.41M | $ 13.43M | $ 124.98M |
| 3/31/2025 | $ 151.33M | $ 13.55M | $ 137.78M |
| 12/31/2024 | $ 181.63M | $ 17.21M | $ 164.41M |
| 9/30/2024 | $ 188.98M | $ 14.82M | $ 174.16M |
| 6/30/2024 | $ 182.36M | $ 11.28M | $ 171.07M |
| 3/31/2024 | $ 112.14M | $ 9.04M | $ 103.1M |
| 12/31/2023 | $ 129.69M | $ 13.3M | $ 116.39M |
| 9/30/2023 | $ 144.49M | $ 9.3M | $ 135.19M |
| 6/30/2023 | $ 153.28M | $ 7.02M | $ 146.26M |
| 3/31/2023 | $ 123.96M | $ 5.68M | $ 118.28M |
Key Performance Insights, Last 5 Years
- ACRIVON THERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 97.49M.
- Over the past 5 years, ACRIVON THERAPEUTICS INC's average Working Capital has been $ 126.41M.
- The median Working Capital for ACRIVON THERAPEUTICS INC during this period was $ 125.28M
- ACRIVON THERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 174.16M.
- The lowest Working Capital recorded by ACRIVON THERAPEUTICS INC in the same timeframe $ 72.28M
Similar metrics to Working Capital:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Working Capital
[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].AssetsC - LiabilitesC
(=) Working Capital Working Capital for ACRIVON THERAPEUTICS INC is calculated as follows: AssetsC [ $ 100.41M ] - LiabilitesC [ $ 2.91M ]
(=) Working Capital [ $ 97.49M ] ACRV - Working Capital, Last 5 years
$ 72.28M
Minimum
Sep 30, 2022
$ 174.16M
Maximum
Sep 30, 2024
$ 126.41M
Average
$ 125.28M
Median
Working Capital Benchmark AnalysisMarket
The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.5M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
| filtered constituents | 2.78K |
|---|---|
| min | $ -465.2M |
| max | $ 607.04M |
| average | $ 96.5M |
| median | $ 32.21M |
| std | $ 173.86M |